|
2025
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
G/S
|
Live animals |
|
|
G/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neuromuscular, muscular, musculos... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide informa... |
|
|
Invention
|
Methods of treatment using a leptin receptor agonist antibody.
Provided herein are therapeutic m... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
Invention
|
Methods of reducing particle formation and compositions formed thereby.
Biopharmaceutical compos... |
|
|
Invention
|
Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same... |
|
|
Invention
|
Genetically modified mice comprising humanized cellular immune system components with improved di... |
|
|
Invention
|
Fabrication of protein-encapsulating microgels.
Methods for fabricating protein-encapsulating mi... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
Invention
|
Novel antigen binding molecule formats.
Antigen binding molecules (ABMs) comprising Fab domains ... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
Invention
|
Methods for producing antigen-binding proteins against foreign antigens.
Methods and composition... |
|
|
Invention
|
Process for reducing subvisible particles in a pharmaceutical formulation.
The present disclosur... |
|
|
Invention
|
Anti-psma antibodies, bispecific antigen-binding molecules that bind psma and cd3, and uses there... |
|
|
Invention
|
Methods for preventing and treating cardiac dysfunction and covid-19 with activin a antagonists. ... |
|
|
Invention
|
Stable antibody formulation.
The present disclosure provides stable pharmaceutical formulations ... |
|
|
Invention
|
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof.
Provided herein are compo... |
|
|
G/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
Invention
|
Characterization of adeno-associated virus using microchip capillary electrophoresis.
Methods an... |
|
|
Invention
|
Nucleic acids encoding anchor modified antibodies and uses thereof.
Described herein are anchor-... |
|
|
G/S
|
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatm... |
|
|
Invention
|
Low concentration vegf receptor fusion protein containing formulations. The present invention pro... |
|
|
Invention
|
Methods and systems for characterizing metal interactions in antibody samples.
Provided herein a... |
|
|
Invention
|
Rodent models of disease. Provided herein are genetically modified rodent models of disease, wher... |
|
|
Invention
|
System and method of categorizing public biomedical databases using large language models. A comp... |
|
|
Invention
|
Recombinant rhabdovirus encoding interleukin-12 (il-12). The application relates to a recombinant... |
|
|
Invention
|
Methods for characterizing proteins in serum samples. Described herein are methods for enriching,... |
|
|
Invention
|
Systems and methods for identifying events in supply chain processes.
A method for identifying a... |
|
|
Invention
|
Compositions and methods for the treatment of myeloproliferative neoplasms. Nucleic acids encodin... |
|
|
Invention
|
Pseudo sample for test method validation. Disclosed herein are a pseudo sample configured for val... |
|
|
Invention
|
Pseudo sample for test method validation.
Disclosed herein are a pseudo sample configured for va... |
|
|
Invention
|
Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m ... |
|
|
Invention
|
Masked multispecific antigen-binding molecules with cleavable linkers.
The present disclosure pr... |
|
|
Invention
|
Masked multispecific antigen-binding molecules with cleavable linkers. e.g.e.g.e.g., a tumor asso... |
|
|
Invention
|
Trivalent multispecific binding molecules and methods of use thereof. The present disclosure rela... |
|
|
Invention
|
Polysorbate and polyoxyethylene sorbitan as excipients for stable protein formulations. The prese... |
|
|
Invention
|
Systems and methods for performing gait and speech assessment associated with a disease state.
E... |
|
|
Invention
|
17beta-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use there... |
|
|
Invention
|
Compositions and methods for treating cytokine release syndrome.
The present invention provides ... |
|
|
Invention
|
Treatment of aneurysms with apolipoprotein c3 (apoc3) inhibitors and gene editing. The present di... |
|
|
Invention
|
Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host... |
|
|
Invention
|
The use of cd40 inhibitors for inhibiting an immune response and enabling immunogen administratio... |
|
|
Invention
|
Human antibodies to the glucagon receptor.
The present invention provides antibodies that bind t... |
|
|
Invention
|
Myosin 15 promoters and uses thereof.
The disclosure provides polynucleotides containing regions... |
|
|
Invention
|
Splicing factor gene mutation-associated neoantigenic peptides and uses thereof. The present disc... |
|
|
Invention
|
Humanized il-6 and il-6 receptor.
Mice that comprise a replacement of endogenous mouse IL-6 and/... |
|
|
Invention
|
Use of a vegf antagonist to treat angiogenic eye disorders.
The present invention provides metho... |
|
2024
|
Invention
|
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof.
This disclosure rela... |
|
2023
|
Invention
|
Methods of treating metastatic castration-resistant prostate cancer with bispecific anti-psma x a... |
|
|
Invention
|
Vectors and methods for in vivo antibody production.
The invention relates to compositions and m... |
|
|
Invention
|
A rodent model of fibrodysplasia ossificans progressiva.
This disclosure relates to a geneticall... |
|
|
Invention
|
Multipartite receptor and signaling complexes.
The present disclosure provides adoptive T cell t... |
|
2022
|
Invention
|
Viral particles retargeted to skeletal muscle.
Provided herein are compositions and methods for ... |
|
|
Invention
|
Methods of treating lung cancer by administering a pd-1 inhibitor.
The present disclosure provid... |
